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Abstract Cis-regulatory regions (CRR) control gene expres-
sion and chromatin modifications. Genetic variation at CRR in
individuals across a population contributes to phenotypic
differences of biomedical relevance. This standing variation
is important for personalized genomic medicine as well as for
adaptive evolution and speciation. This review focuses on
genetic variation at CRR, its influence on chromatin, gene
expression, and ultimately disease phenotypes. In addition, we
summarize our understanding of how this variation may con-
tribute to evolution. Recent technological and computational
advances have accelerated research in the direction of person-
alized medicine, combining strengths of molecular biology
and genomics. This will pave new ways to understand how
CRR variation affects phenotypes and chart out possible ave-
nues of intervention.
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Introduction
How individual genotypes relate to phenotypes is one of the
key questions in biology today. Humans within the same
population show substantial phenotypic variation in terms of
physical properties, behavior, and susceptibility to diseases.
This is largely attributed to the genetic variation and environ-
mental differences during growth and development. With the
advent of individual genome sequencing, it should be possible
to associate genetic variation with certain phenotypic traits,
more importantly those of biomedical relevance. Indeed, per-
sonalized medicine promises to customize medical decisions
tailored to the genome sequence information of the patient.
Thus, the challenge of modern molecular biology and medi-
cine is to make critical predictions about an individual’s health
based on his/her entire genome sequence. While we are far
from making such a causal link, new approaches associate
genetic variation within a population to differences in biomed-
ical profiles of individuals.
Genome-wide association (GWA) studies typically com-
pare the probability of certain genetic variants occurring in
control and diseased groups to infer if these variants are linked
with susceptibility to the disease. Such unbiased studies have
been very successful in documenting risk loci associated with
diseases like cancers, stroke, and coronary heart conditions, as
well as pharmacological traits such as drug efficacy and
adverse responses to drugs (Ku et al. 2010; Manolio 2013;
McCarthy et al. 2008). While GWA studies only suggest
possible loci involved, mechanistic work in disease models
is required to firmly establish the causality between genetic
variation at these loci and disease susceptibility. About 90 %
of loci associated with human diseases fall in non-coding
regions of the genome (Hindorff et al. 2009; Maurano et al.
2012; Nicolae et al. 2010). How do the variations in these
regions control complex diseases without coding for proteins
themselves? Work over the last few decades has elegantly
shown that non-coding intergenic regions of the genome are
vital in deciding the space, the time, and the quantity of gene
expression, and hence protein abundance. The significance of
genetic variation at these cis-regulatory regions (CRR) is the
central theme of this review. We set out by defining the key
features of CRR and how they influence the surrounding
chromatin architecture and cellular properties. We will then
critically evaluate a few instances of medically relevant CRR
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and their link to chromatin landscape. We discuss how varia-
tion at CRRmay have played an important role in evolution of
new species. Finally, the recent excitement in linking genetic
and chromatin variation within a population is summarized,
highlighting the tremendous potential of whole-genome se-
quencing efforts.
CRR, chromatin and transcriptional regulation
Since the discovery of cis-regulatory control of transcription
by Jacob and Monod half a century ago, we have learned a
large number of molecular rules that govern gene expression.
While many genomes have extensive intergenic regions, not
all of these regions regulate gene activity. How do we identify
CRR in the large gene-deserts of the genomes to systemati-
cally annotate them? At least four criteria have been used in
order to prioritize genomic regions that may have a strong
functional role: (1) the presence of clustered TF binding site
motifs as inferred by sequence analysis, (2) actual occupancy
by chromatin proteins as shown by genome-wide chromatin
immunoprecipitation (ChIP) experiments either in cell lines or
tissues, (3) biochemical signatures of gene regulation such as
histone marks, and (4) regions that are under evolutionary
constraint identified by comparing syntenic DNA sequences
of related species. Additionally, recent studies have performed
unbiased screens for regulatory regions that control gene
expression, highlighting enhancers that had been hitherto
unknown (Arnold et al. 2013). CRR control various aspects
of genomic regulation including transcriptional and post-
transcriptional gene expression, RNA splicing, and DNA
replication timing. Genetic variation in UTRs or exon/intron
junctions will likely affect mRNA stability via miRNA bind-
ing and alternative splicing, respectively. Additionally, poly-
morphisms at DNA replication originsmay alter the frequency
of DNA replication from those sites. Several studies have
reported genetic variation in human population at such sites,
even in connection with diseases (Graham et al. 2007; Haas
et al. 2012; Rademakers et al. 2008; Wang et al. 2008). This
review will focus, however, on the genetic variation at tran-
scriptional control elements like promoters and enhancers.
Transcription factors (TFs) typically bind specific DNA
sequences in regulatory regions such as enhancers and facilitate
the regulation of target genes by chromatin modifications and
influencing RNA polymerase activity. Chromatin forms an
important regulatory layer between DNA-binding TFs and
gene regulation. More importantly, chromatin integrates
DNA-encoded genetic information with heritable environmen-
tal influences (epigenetic information). Chromatin at function-
ally important and active regions such as enhancers and pro-
moters is not highly compacted by nucleosomes and is termed
as “open chromatin”. These regions are sensitive to digestion
by DNase, and hence are referred to as DNase hypersensitive
sites (DHS). Post-translational modifications of promoter-
associated histones such as trimethylation at lysine 27 on
histone H3 (H3K27) and H3K4 have been linked with gene
repression and activation, respectively. In some cases, both
these marks appear simultaneously at promoters representing
a poised state of bivalency; these promoters are thought to be
ready for activation upon differentiation and are likely to be
subjected to the effects of genetic variation (see below). H3K27
and H3K4 trimethylation marks are set by Polycomb and
trithorax chromatin-modifying systems (Sawarkar and Paro
2010). On the other hand, several acetyltransferases also act
on H3K27 and antagonize the repressive methylation mark set
by the Polycomb system. In contrast to promoters, enhancers
exhibit a more restricted mark of H3K4 monomethylation and
are thought to show chromatin-mediated regulation.
Additionally, H3K27 acetylation mark indicates an active en-
hancer and exhibits dynamic control (Calo andWysocka 2013).
Moreover, CRR exhibit methylation at CpG, typically correlat-
ed with gene repression. Often decorated with specific chroma-
tin modifications, CRR variation may even alter the respon-
siveness to external cues by changing the accessibility of chro-
matin to environment-regulated TFs. Genetic variation at CRR
may influence the surrounding chromatin composition and
gene activity at steady state or under environmental dynamics,
and ultimately the phenotype at large (Fig. 1). Very recent work
has provided empirical evidence on a global scale for this flow
of information from variation in DNA sequences to differences
in gene activity and surrounding chromatin.Whether chromatin
plays an instructive role in this process or is merely consequen-
tial to the sequence changes is still a matter of debate.
Standing genetic polymorphism at CRR and consequent
chromatin variation
That CRR play a crucial role in directing gene activity may
suggest a low genetic variation associated with CRR within a
population, just like the coding variation. However, unlike
protein-coding variation, CRR variants are likely to affect only
a small set of target genes and hence may exhibit only mild
deleterious effects. The effect of variation in protein-coding
sequences is easy to comprehend in terms of changes in amino
acid sequence, and possible consequences on binding, enzy-
matic activity, or signal transduction. In exceptional cases,
variation in the coding regions might also be constrained by
the dual use of exonic regions as CRRs (Stergachis et al. 2013).
However, variation in CRR is difficult to assess, as the genome-
wide annotation of CRR is still coarse-grained with uncertain
TF motif definitions and unknown boundaries. To get a full
spectrum of the standing genetic variation at CRR including
SNPs, insertions, and deletions, at least three aspects have to be
considered. First, full genome sequences of sufficient quality
from several unrelated individuals within a population need to
be examined. Exome sequencing restricted to exons (Bamshad
et al. 2011), mainly coding parts of the genome, is now being
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substituted by whole genome sequencing, allowing CRR var-
iation to surface. An initial plan of fully sequencing 1,000
human genomes from different ethnicities/races is bearing fruits
(http://www.1000genomes.org/). Second, a detailed
understanding of the CRR within the genome is required.
Large consortia like ENCODE facilitate systematic annotation
of CRR within the human genome by analyzing several
chromatin marks and TF binding in different human cell
types (Bernstein et al. 2012). Third, knowledge of variation
that can cause quantitative changes in gene expression in
defined cell types [called expression quantitative trait loci
(eQTLs)] will be useful in discerning causality (Brown et al.
2013; Gilad et al. 2008; Majewski and Pastinen 2011; Morley
et al. 2004). Combined whole genome and RNA sequencing of
mother–father–child trios is now becoming common allowing
an assessment of the inheritance patterns of chromatin varia-
tion. Thus, the stage is set to functionally unravel CRR-
associated genetic variation within human populations.
Fig. 1 Linking genotypes with cellular phenotypes via chromatin. a Some
transcription factors (such as PU.1 or AP1) act as pioneering factors at
H3K4me1/2-decorated enhancer sites and induce chromatin modifications.
Genetic variants disrupting their cognate DNA-motif (red star) reduce
binding of the respective transcription factor, shown here in a lighter shade
of orange (e.g., CRR variant 2 and 4). b After opening of the chromatin,
further transcription factors can bind in a collaborative manner under the
influence of extracellular environment. Histone acetyltransferases, like
p300, get recruited to the activated enhancer sites. Reduced binding of the
initial transcription factor decreases the average ChIP-signal of H3K27ac at
the mutated locus, shown here as dotted ovals (variant 2). In a similar
manner, mutations in the motifs belonging to downstream transcription
factors also decrease the observedChIP-signal (variant 3). Combined effects
of both mutations are even stronger due to the hierarchical nature of the
process (variant 4). c Variation in the activity of the upstream enhancer
results in variation in Pol II recruitment and trimethylation of H3K4 at
transcription start sites (TSS). Again, differential ChIP-signals can be ob-
served for all the cases, consequently leading to dissimilar RNA levels (d). e
The underlying genetic changes lead to variation of a quantitative trait, in
this example, the expression of a cell surface receptor. However, the process
might be buffered at several post-transcriptional stages, thereby fixing the
natural range of the quantitative trait
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The first results of the 1,000-genomes project clearly show
that each of the studied individuals carried hundreds of non-
coding variants at conserved sites (Abecasis et al. 2012).
Many of these variants disrupt TF motifs, and may have
functional consequences. Most individual variant alleles were
at low frequency in human populations, possibly due to recent
population growth and weak selection, just as seen for protein-
coding variation (Tennessen et al. 2012). Genome sequences
of people from different ethnic backgrounds provide a unique
opportunity for studying natural selection and fixation of
alleles in human populations.While CRR variation may affect
protein amounts within a cell, variation in protein sequences,
especially that of TFs, may affect their binding to DNA. Not
surprisingly then, studies have found that CRR and coding
variation can influence each other such that an effect of a
coding variation is contingent upon a CRR variant
(Lappalainen et al. 2011).
The large genetic variation at CRR found in human popu-
lations hints at possible chromatin variation in cis, i.e. changes
in chromatin properties in an allele-specific manner. Such an
exciting analysis is technically challenging owing to the
amounts of samples required to assess chromatin properties
genome-wide. In the last few years this has become possible
due to the establishment of lymphoblastoid cell lines from
people of distinct geographical and racial backgrounds (Frazer
et al. 2007; HapMap-Consortium 2003). Additionally, some
cell lines came from parents–offspring trios, facilitating anal-
ysis of inheritance. These cell lines are an unparalleled re-
source for which genotype, gene expression, chromatin land-
scape, and pharmacogenomic information has been made
available (Dixon et al. 2007; Jones et al. 2007; Morley et al.
2004; Spielman et al. 2007; Storey et al. 2007; Stranger et al.
2007; Zhang et al. 2008). Moreover, the cell-type-specific
effect of CRR variation is also being analyzed within the
GenCord project (Dimas et al. 2009). Using these resources,
several recent studies set out to decipher fundamental princi-
ples of how genetic variation can affect gene expression and
chromatin modifications. Integrative genome-wide analyses
of DNA sequence variation combinedwith differences in gene
expression and several chromatin properties in these cell lines
were performed. A variety of chromatin-related factors were
tested, namely DNase I hypersensitivity that indicates open
chromatin, several histone modifications marking active and
repressed chromatin, RNA pol II activity, occupancy of TF,
and selected chromatin proteins. In addition to gene expres-
sion variation, all the studies confirmed the existence of large
chromatin differences across individuals. This included vari-
ation in DNase hypersensitivity, DNAmethylation, and active
and repressive chromatin marks at promoters and enhancers
(Bell et al. 2011; Degner et al. 2012; Gutierrez-Arcelus et al.
2013; Kasowski et al. 2013; Kilpinen et al. 2013; McVicker
et al. 2013). Such chromatin variation was stable over gener-
ations of cultured cells, and was strongly associated with the
nearby genetic variation at CRR. Enhancers and promoters
that exhibit both active and repressive chromatin marks (bi-
valent regions) show large variation in different histone marks
when compared with their active or inactive counterparts
(Kasowski et al. 2013). Moreover, all the studies converged
on motif-disrupting TF binding site variation that correlated
with changes in nearby chromatin marks, suggesting that TF
binding is instructive in setting chromatin marks. For exam-
ple, an NF-kB motif in the genome showed genetic variation
that strongly correlated with differential NF-kB binding and
DNase I hypersensitivity (Degner et al. 2012). Moreover,
histone marks at multiple places could be associated with a
single DNA variant (Fig. 1; McVicker et al. 2013), possibly
via chromosomal contacts like enhancer–promoter looping.
Conversely, variation at multiple TFs can correlate with a
single histone mark: PU.1 and Myc binding correlates with
H3K27Ac (Kilpinen et al. 2013). Interestingly, studies have
shown that different TF binding events can cooperate with
each other such that variation in one motif affects binding of a
distinct TF nearby (Karczewski et al. 2011; Kilpinen et al.
2013), thus affecting chromatin.
Two issues have to be kept in mind while interpreting these
data. First, the individual cell lines, though representative of
the original genomes, show different growth rates in culture
due to unknown reasons (Stark et al. 2010). This may affect
gene expression and chromatin. Second, the association of
chromatin variation with TF motif changes may not reflect a
direct biochemical role of TFs in modifying local chromatin.
The differences in chromatin may well be a consequence of
gene expression changes set up by CRR variation.
Nonetheless, these studies provide the much-awaited empiri-
cal data showing that the genetic variation within human
populations affects gene expression and chromatin in ways
that can be predicted. Most importantly, the studies put TFs at
the centre-stage of population genetics linking genetic varia-
tion with gene regulation and chromatin. The concept of TF
binding to variant enhancers leading to differential gene ex-
pression has recently been confirmed using natural genetic
variation in mouse strains (Heinz et al. 2013). This under-
scores the huge impact enhancer variation can have on chro-
matin and ultimately phenotype. The picture is even more
complex if one considers several tissue types with distinct
enhancers.
CRR variation and buffering
Although TF motif variation affects nearby chromatin profiles
and even nascent transcription, steady-state mRNA levels
have been shown to exhibit much less variation (Kasowski
et al. 2013; Kilpinen et al. 2013). This could either mean that
there is non-consequential genetic variation or that there are
ways in which variation can be buffered or compensated for.
In some cases, multiple TF motifs occurring within CRR may
498 Cell Tissue Res (2014) 356:495–505
allow motif-disrupting or motif-generating variation at a few
local sites without altering the regulatory capacity.
Additionally, a gene may be controlled by several enhancers
and hence simultaneous alterations at multiple enhancers
could be required for changes in gene expression. While
variation at a single enhancer may cause local chromatin
changes, it may not affect the target gene expression unless
other enhancers also show variation. In other cases, this com-
pensatory mechanism can be post-transcriptional since the
large variability in nascent transcription across human indi-
viduals is not reflected in the variation of mRNA abundance.
The simplest mechanism is temporal averaging of mRNA
produced by a locus owing to the longer half-life of mRNA
molecules compared with the transcriptional event per se. An
alternative hypothesis proposes that special buffering mecha-
nisms operate at chromatin (Spivakov et al. 2012). Molecular
chaperones such as heat-shock protein 90 (Hsp90) have been
thought of as a general buffer against protein-coding variation
as they can bind to and fold minor variants of proteins (Jarosz
et al. 2010). Given Hsp90 is also located at chromatin
(Sawarkar and Paro 2013; Sawarkar et al. 2012), it may
possibly buffer CRR variation by allowing TFs to bind to
the variant DNA with an almost equal affinity. An exciting
outcome of this is the possibility that the variation can become
responsive to environmental stress: Hsp90’s buffering ability
may be reduced during conditions of stress. Consequently,
CRR variation may result in differential TF binding only upon
stress, leading to chromatin and expression differences.
Theoretically, such a mechanism also explains gene–environ-
ment interactions that are vital to population genetic studies.
CRR variation and human health
Studies from model organisms like Drosophila have shown
that single mutations in CRR can cause severe developmental
abnormalities (e.g., Gyurkovics et al. 1990). However, this
does not directly imply that population-wide genetic variation
at CRR may be causally associated with human diseases. As
compared to coding regions, several reasons have prevented
CRR from being empirically correlated with diseases in hu-
man populations. Practically, the majority of genome-wide
studies focus on exomes that are mostly representative of the
protein-coding fraction of the genome (Bamshad et al. 2011),
excluding CRR from consideration. Additionally, global
GWA studies often focus on functionally validating the effects
of protein-coding variants since they are rather straightfor-
ward. Polymorphisms within CRR are challenging to inter-
pret, as it is difficult to infer whether a particular variant will
affect any function. Finally, CRR variation affecting en-
hancers is likely to have a highly tissue-specific defect.
Unless the right disease model or cell-type is employed for
validation, functional consequences of CRR variation can be
easily missed. Nonetheless, unbiased GWA studies have
indicated that 80–90 % of the disease QTLs fall outside
coding genes (Hindorff et al. 2009; Maurano et al. 2012;
Nicolae et al. 2010). Interestingly, many of these loci coincide
with DNase-sensitive regions, indicating that active chromatin
harbors a large fraction of disease-causing polymorphic sites
(Maurano et al. 2012). Several new studies have taken the
bold step of molecularly linking these CRR variants with
chromatin and gene expression alterations as summarized in
the following section and in Table 1.
Similar to protein-coding genes, CRR variation can be
linked to diseases with classic Mendelian traits such as hemo-
philia as well as with more complex multifactorial syndromes
like diabetes, cancers, and blood cholesterol levels (Dodd
et al. 2013; Gaulton et al. 2010; Musunuru et al. 2010;
Pomerantz et al. 2009; Stitzel et al. 2010; Weedon et al.
2014). The key issue is to establish a causal association
between CRR variants and disease outcomes, as GWA studies
only indicate co-occurrences. For a complex syndrome, a
molecular phenotype that represents the disease helps settling
the case of causality, as shown for hemophilia B. Mutations in
the clotting factor IX (F9) lead to monogenic disorder hemo-
philia B. Several of these causal variants are found in CRR of
the F9 gene that disrupt binding sites of C/EBP-alpha or
HNF4 TFs (Funnell and Crossley 2014). These genetic vari-
ants most likely alter chromatin and mRNA expression of the
clotting factor gene, leading to hemophilia of a certain sub-
type. In such a case of a monogenic simple trait, discordance
between such mutations and disease symptoms might shed
light on putative modifier loci. These may include variants
within the CRR itself or genes encoding the cognate TFs.
GWA studies of fetal hemoglobin levels have pointed to
several CRR variants, some which fall near the gene encoding
the repressor of fetal haemoglobin, BCl11A. Recent studies
have found one such variant that abolishes GATA1 and
Tal1 binding site, affecting chromatin and transcription of the
repressor BCL11A altering fetal hemoglobin levels
(Bauer et al. 2013).
The genetic and environmental contributions to cancer sus-
ceptibility are being intensely investigated. GWA studies have
allowed empirical realization of this issue and have mapped
several genetic variants. In one case, a breast cancer risk allele
was shown to harbor a single SNP within a FOXA1 binding
motif near a tumor suppressor gene (Cowper-Sal.lari et al.
2012). The genetic variant altered FOXA1 binding, and conse-
quently changed the cognate gene expression, increasing the
susceptibility of carrier individuals to breast cancer. Another
study has underlined the importance of p53 binding sites in
CRR of KITLG, a gene implicated in various cancers (Zeron-
Medina et al. 2013). The variant causes misregulation of
KITLG, presumably accompanied by altered chromatin prop-
erties, increasing susceptibility to cancers. The mechanism of
enhanced risk of cancer associated with this particular genetic
variant is not clear, but could involve other components of
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chromatin/transcriptional regulation. Similarly, the molecular
underpinnings of asthma susceptibility have implicated a com-
bination of genetic variation and DNA methylation at the
Interleukin 4 receptor gene (Soto-Ramirez et al. 2013). Such
studies, when performed genome-wide, will likely lead to an
improved understanding of the gene–environment interaction
involving epigenetic marks. Additional studies are summarized
in Table 1.
Most studies prioritize non-coding variant candidates in
GWA studies by comparing conservation of surrounding se-
quences and known ChIP/histone marks. Consequently, these
studies look for loss-of-function variation, e.g., when a highly
conserved TF motif is mutated. However, a variant could also
create a new TF binding motif in a region that shows little
evolutionary conservation or histone marks. A variant that
creates GATA-1 TF motif has been reported near the alpha
globin gene (De Gobbi et al. 2006). This promoter-like
element, in a region that is otherwise neutral in its regulatory
potential, recruits several erythroid lineage TFs. The resultant
chromatin structure appears to restrict activation of the cognate
alpha globin gene leading to thalassemia. This highlights the
importance of taking an unbiased approach in interpreting
variants from GWA studies, especially when looking at CRR.
CRR variation and evolution
Molecular evolution is typically studied across closely related
species, which gives insight into how genomic sequences
change over evolutionary time scales. It can also identify loci
that may have actually contributed to the process of divergence.
How important are the changes in CRR to adaptive evolution?
Work in a variety of species has indicated that CRR have the
potential to aid species divergence. However, their relative
contribution to molecular evolution compared with coding
Table 1 Recent findings coupling cis-regulatory mutations and human diseases
Associated genetic variant Impact on molecular phenotype and health
Creation of a new C/EBP binding site at the
1p13 locus
Binding of C/EBP transcription factors to a cognate binding site, which was
newly created by a CRR variant, modulates expression of SORT1 in hepatocytes.
This has been shown to directly influence low-density lipoprotein cholesterol
(LDL-C) levels, a known risk factor for myocardial infarction (Musunuru et al. 2010).
Disruption of a binding site for STAT1 at the
9p21 locus
Two CRR variants associated with coronary artery disease (CAD) disrupt a predicted
STAT1 binding motif. This enhancer changes its associations dependent on
interferon-γ signaling. Thus, the risk alleles may become contingent upon
inflammatory responses (Harismendy et al. 2011).
Alteration of a FOXA1 binding sites at the
16q12 locus
Several CRR variants that are associated with breast cancer modulate the affinity
of the forkhead protein FOXA1 to chromatin. A specific CRR variant could be
shown to repress the tumor suppressor TOX3 gene via FOXA1 binding
(Cowper-Sal.lari et al. 2012).
Disruption of an ETS-binding motif/ E-box element
within the intronic region of the GATA2 gene
MonoMAC syndrome characterized by mono- and lymphocyte deficiencies
is typically associated with reduced function of GATA2. Mutations in the
enhancer of the gene, located in an intron, cause GATA2 expression defects
and consequently the syndrome (Hsu et al. 2013).
Disruption of an enhancer motif driving TBX5
expression during heart development
Patients with Holt–Oram syndrome suffer from impaired heart and hand development
before birth. A mutation in an enhancer bound by an unidentified transcription factor
affects the expression of TBX5 gene during heart development. People homozygous
for the motif-disrupting allele show congenital heart defects (Smemo et al. 2012).
Polymorphisms in the near vicinity of a HIF
binding motif at the 11q.13.3 locus
Common variants near the binding-motif of the hypoxia-inducible factor (HIF) modulate
the activity of the enhancer as well as the allelic expression of CCND1, a known oncogene.
GWA studies associated the implicated SNPs with kidney cancer (renal cell carcinoma,
RCC) and further results showed the enhancer to be active in an RCC-specific background
(Schoedel et al. 2012).
Deletion of an EGR2 enhancer The transcription factor EGR2 regulates the development of the myelin sheath in the
peripheral nervous system. Homozygous deletion of an enhancer, the myelinating Schwann
cell element (MSE), controlling the expression of EGR2 results in the lack of myelin and
subsequently causes congenital neuropathy (Funalot et al. 2012).
Six recessive mutations that abolish the activity
of an enhancer regulating the PTF1A gene.
Patients suffering from non-syndromic pancreatic agenesis fail to undergo normal development
of the pancreas. This leads to neonatal diabetes mellitus and exocrine pancreatic insufficiency.
The PTF1A gene encodes a TF that regulates pancreatic development and is itself controlled
by a conserved enhancer region 25 kb downstream of its promoter. Disruption or deletion
of several binding motifs within this conserved region prevents binding of FOXA2, PDX1,
and an unknown TF resulting in an inactivation of the PTF1A gene (Weedon et al. 2014).
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sequences is still debated (Hoekstra and Coyne 2007; Linnen
et al. 2013). CRR changes tend to be less pleiotropic with
milder fitness effects as compared to coding sequences, since
the former controls only a small set of genes directly, typically
one or two. Also, variation at tissue-specific enhancers is likely
to affect the phenotype of that specific tissue, unlike protein
variants that affect all the tissues in which that protein is
expressed. Therefore, it has been argued that natural selection
operates differently (and possibly more effectively) on CRR-
based genetic variation resulting in 'fine-tuning' of quantitative
traits (Wray 2007).
Changes in the regulatory landscape have been linked to
the evolution of vertebrates. A recent study found three
'waves' of regulatory gains during the origin of vertebrates.
The first gains occurred in regions regulating key transcription
factors and developmental genes, the second wave included
gains at genes linked to extracellular signaling, and the last
changes happened in CRR of genes encoding post-
translational protein modifiers (Lowe et al. 2011). In a similar
manner, adaptive, species-specific gains of DHS sites have
been connected with the origin of humans. Changes in the
chromatin accessibility of genes among primates are correlat-
ed to differential gene expression patterns and ultimately to
different phenotypic traits (Shibata et al. 2012). Elegant stud-
ies have linked development of wing spots in closely related
Drosophila species to causal variants at tissue-specific en-
hancers of certain genes (Arnoult et al. 2013). Yet another
example for the importance of CRR in evolution is the devel-
opment of new CTCF binding sites in several Drosophila
species (Ni et al. 2012). CTCF binding sites are well-known
insulator elements and, although the CTCF binding motif is
highly preserved, the binding behavior of CTCF differs
among these Drosophila species. The birth of new CTCF
binding sites is subject to purifying selection and correlates
with species-specific transcription profiles in adjacent genes
and the birth of new genes. This raises the question whether
changes in the chromatin architecture are needed for the
development of new traits, and hence new species.
While genomes of several related species have been se-
quenced, different individuals within the same species are only
now being intensely investigated: e.g., the 1,000-genome pro-
ject documenting the variation among humans. Within-species
standing variation is the real substrate upon which natural
selection operates. Thus, by comparing individual genomes
inhabiting different geographic niches, it is possible to connect
selection forces with genetic determinants. An example of
adaptive selection at a TF binding site is the human DARC
locus where a causal SNP in a CRR disrupts binding of
GATA1, leading to altered expression of the gene specifically
in erythrocytes. Since DARC is a receptor for the entry of
malarial parasite, differential expression of this protein has an
impact on resistance against malaria. The binding sites of
GATA1 have been shown to exhibit a strong amount of positive
selection in human evolution corresponding to the prevalence
of malaria within ecological niches (Arbiza et al. 2013). What
might then be a connection between conservation of CRR
across different species and the genetic variation at these
CRRs across individuals of the same species? Loss of TF
binding sites in Drosophila species may result from the gene
expression variation within species. For example, geographi-
cally isolated strains may undergo drift or adaptive selection on
gene expression. These changes may then be fixed as a loss of
TF motifs during speciation. Both these phenomena have been
observed in Drosophila (Hutter et al. 2008; Kim et al. 2009),
but their empirical relationship with each other remains unclear.
Thus, genetic variation at CRR may already exist within a
population that can be fixed during speciation, either by adap-
tive selection forces or by chance.
Theoretically, genetic variation at CRR may impact the
intensity of binding of TFs if the variation modifies the cog-
nate core motif. However, studies have indicated that variation
in the core motif does not always modify the TF binding
intensity. Rather, binding behavior depends on the sequence
context in which the motif exists. For example, polymorphism
at conserved CTCF binding sites has much less effect on
CTCF ChIP signals than similar mutational changes in bind-
ing sites that were not conserved among species (Spivakov
et al. 2012). Furthermore, these effects could not be explained
by additional CTCF motifs in the near vicinity, as 96 % of the
surveyed loci only contained a single binding site. These
findings suggest additional buffering mechanisms, e.g., some
possibly mediated by Hsp90 (see above), that stabilize the
binding of transcription factors at conserved regions. An
exciting possibility is that functional genetic variation at heat
shock loci might impact speciation in times of stress. Indeed,
changes in core promoter sequences of these genes are linked
with varying expression of heat shock proteins in different
species of the fly Liriomyza (Chen et al. 2011).
The role of chromatin in linking CRR variation to phenotype
As summarized above, many studies have demonstrated dif-
ferences in chromatin properties owing to changes in CRR
sequences that correlate with diseases or are linked with
speciation. The critical question is whether chromatin plays
an instructive role in such instances. This issue touches on an
important debate in epigenetics as to the relevance of heritable
chromatin changes in establishing phenotypic variation
(Ptashne 2013; Ptashne et al. 2010). In most of the examples
cited throughout this text, TF binding site variation, and hence
DNA sequence differences, is the cause of chromatin and gene
expression changes. These studies do not even address the
importance of chromatin, as they investigate genetic changes
as a basis for phenotypic variation. Recent studies have
employed clever experiments to dissect this conundrum. It is
known that the heat-shock transcription factor (HSF), like
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most other TFs, only binds to a subset of binding motifs in the
genome. One of the explanations for this observation is that
motifs in certain genomic regions are not available for TF
binding due to the local chromatin architecture. Artificially
increasing DNA accessibility in these regions allows TF bind-
ing (Guertin and Lis 2010). These observations suggest that
chromatin may play a crucial role in deciding whether or not a
TF can bind to its cognate motif. How is local chromatin
architecture controlled? Possibly this is via heritable epigenet-
ic systems that can be activated by developmental or environ-
mental signals (Cavalli and Paro 1998). Interestingly, work in
plants has shown that variation in DNA methylation linked
with certain traits can be transmitted across generations, even
in the absence of DNA sequence variation (Johannes et al.
2009). This underscores the plausibility of heritable epigenetic
variation playing an instructive role in gene regulation and
phenotypes. An even more direct evidence that chromatin
modifications can play an instructive role in gene expression
comes from recent epigenome editing studies. By experimen-
tally manipulating local chromatin over CRRs, cognate gene
expression could be modified (Konermann et al. 2013;
Maeder et al. 2013; Mendenhall et al. 2013). Such studies
can provide a direct evidence of the role of chromatin marks in
influencing transcription: DNA and histone modifications
need not be a passive consequence of RNA pol II activity in
all these cases. However, these studies are carried out in
uniform genetic backgrounds, thus cannot assess the rele-
vance of chromatin in the context of natural CRR variation.
To gain more insights into such roles of chromatin, three
model systems with controlled genetic and/or environmental
backgrounds are being used. First, research on monozygotic
twins allows us to understand how different CRR variants are
subjected to environmental influences in identical pairs (Bell
and Spector 2011). Second, the follow-up studies of the fa-
mous case of Dutch famine provides an opportunity to eval-
uate how prenatal environment can have lasting influence in a
real-life situation, presumably via nongenetic alterations
(Lumey et al. 2007). Finally, population genetics of model
organisms likeD. melanogaster is a rich source of information
on chromatin, as both genetic and environmental backgrounds
can be controlled (Mackay et al. 2012). Harnessing genetic
variation in natural populations will pave a way for
critically establishing contributions of chromatin and
genetic factors. These studies are beginning to unravel
the complex interplay between chromatin and CRR
variation.
Concluding remarks
It is becoming increasingly clear that CRR show substantial
genetic variation withinmembers of a population.Much of the
variation affects expression of genes via its impact on TF
binding and consequent effects on chromatin, thus affecting
human health and susceptibility to diseases. Considerable
evidence suggests the involvement of CRR variation in natu-
ral selection and adaptation. Our molecular comprehension of
gene regulation is paving new ways for understanding how
CRR variation can impact biomedicine, ecology, and evolu-
tionary biology.While most studies show correlations of CRR
variation and phenotypic differences, a key issue is establish-
ing a causal association and hence predicting the outcome of
CRR variation (Cooper and Shendure 2011). Aspects such as
the complexity of gene regulation, redundancy and interaction
between cis and trans elements have to be taken into account.
Gene–environment interactions, possibly via heritable epige-
netic modifications, should also be considered in future stud-
ies. Incomplete penetrance of most CRR variants, lack of our
knowledge on modifier loci, and the possibility of buffering
mechanisms complicate the analyses. However, modern sys-
tems biology and computational tools (Evangelou and
Ioannidis 2013; Patnala et al. 2013), large sets of population
genomic datasets, and ever-decreasing sequencing costs are
making genetic variation studies more realistic. In connecting
molecular biology with such disparate areas as medicine and
evolution, the exciting research on genetic variation truly
integrates all of biology.
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